DK0537191T3 - Behandling af organtransplantat-afstødning - Google Patents

Behandling af organtransplantat-afstødning

Info

Publication number
DK0537191T3
DK0537191T3 DK91910880T DK91910880T DK0537191T3 DK 0537191 T3 DK0537191 T3 DK 0537191T3 DK 91910880 T DK91910880 T DK 91910880T DK 91910880 T DK91910880 T DK 91910880T DK 0537191 T3 DK0537191 T3 DK 0537191T3
Authority
DK
Denmark
Prior art keywords
treatment
graft rejection
organ graft
fluoro
carboxylic acid
Prior art date
Application number
DK91910880T
Other languages
English (en)
Inventor
Neil Richard Ackerman
Bruce Donald Jaffee
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Application granted granted Critical
Publication of DK0537191T3 publication Critical patent/DK0537191T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91910880T 1990-06-11 1991-06-05 Behandling af organtransplantat-afstødning DK0537191T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/535,672 US5204329A (en) 1990-06-11 1990-06-11 Treatment of organ transplantation rejection
PCT/US1991/003788 WO1991019498A1 (en) 1990-06-11 1991-06-05 Treatment of organ transplantation rejection

Publications (1)

Publication Number Publication Date
DK0537191T3 true DK0537191T3 (da) 1998-10-07

Family

ID=24135268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91910880T DK0537191T3 (da) 1990-06-11 1991-06-05 Behandling af organtransplantat-afstødning

Country Status (14)

Country Link
US (1) US5204329A (da)
EP (1) EP0537191B1 (da)
JP (1) JPH05507697A (da)
KR (1) KR930700107A (da)
AT (1) ATE165511T1 (da)
AU (1) AU664354B2 (da)
CA (1) CA2085002A1 (da)
DE (1) DE69129332T2 (da)
DK (1) DK0537191T3 (da)
ES (1) ES2114888T3 (da)
IE (1) IE911962A1 (da)
IL (1) IL98425A (da)
WO (1) WO1991019498A1 (da)
ZA (1) ZA914456B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06116151A (ja) * 1991-08-06 1994-04-26 Asahi Chem Ind Co Ltd 増殖性皮膚疾患治療用組成物
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
US6770279B1 (en) * 1992-10-08 2004-08-03 The Kennedy Institute Of Rheumatology TNFα antagonists and cyclosporin in therapy of rheumatoid arthritis
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US6171585B1 (en) 1993-05-14 2001-01-09 Cedars-Sinai Medical Center IVIg immunosuppression in HLA-sensitized transplant recipients
US20020068057A1 (en) * 1994-03-10 2002-06-06 Marc Feldmann Treatment of autoimmune and inflammatory disorders
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
WO1997042953A1 (en) * 1996-05-10 1997-11-20 Novartis Ag Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
EP0991623A2 (en) 1997-06-19 2000-04-12 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
UA65587C2 (en) * 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
WO1999038846A1 (en) * 1998-01-30 1999-08-05 Procept, Inc. Immunosuppressive agents
TW581681B (en) * 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
WO1999050388A1 (en) * 1998-03-27 1999-10-07 Chong Kun Dang Corporation Streptomyces sp. producing tautomycetin and immunosuppressant comprising tautomycetin as active ingredient
US7323471B1 (en) * 1999-08-13 2008-01-29 Dor Biopharma, Inc. Topical azathioprine for the treatment of oral autoimmune diseases
AU2014352920A1 (en) 2013-11-22 2016-06-23 Genzyme Corporation Novel methods for treating neurodegenerative diseases
WO2015120317A1 (en) * 2014-02-07 2015-08-13 Neurocrine Biosciences, Inc. Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof
US11406707B2 (en) * 2014-02-10 2022-08-09 H. Lee Moffitt Cancer Center And Research Institute, Inc. STAT3 phosphorylation during graft-versus-host disease
TN2018000121A1 (en) 2015-10-30 2019-10-04 Neurocrine Biosciences Inc Valbenazine salts and polymorphs thereof
CN108925135A (zh) 2015-12-23 2018-11-30 纽罗克里生物科学有限公司 制备(S)-(2R,3R,11bR)-3-异丁基-9,10-二甲氧基-2,3,4,6,7,11b-六氢-1H-吡啶并[2,1-a]异喹啉-2-基2-氨基-3-甲基丁酸酯二(4-甲基苯磺酸盐)的合成方法
AU2017395703B2 (en) 2017-01-27 2021-09-23 Neurocrine Biosciences, Inc. Methods for the administration of certain VMAT2 inhibitors
WO2019060322A2 (en) 2017-09-21 2019-03-28 Neurocrine Biosciences, Inc. HIGH DOSAGE VALBENAZINE FORMULATION AND COMPOSITIONS, METHODS AND KITS THEREOF
EA202090932A1 (ru) 2017-10-10 2021-05-20 Нейрокрин Байосайенсиз, Инк Способы введения некоторых vmat2-ингибиторов
US10993941B2 (en) 2017-10-10 2021-05-04 Neurocrine Biosciences, Inc. Methods for the administration of certain VMAT2 inhibitors
SG11202100303QA (en) 2018-08-15 2021-02-25 Neurocrine Biosciences Inc Methods for the administration of certain vmat2 inhibitors
US10940141B1 (en) 2019-08-23 2021-03-09 Neurocrine Biosciences, Inc. Methods for the administration of certain VMAT2 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6592M (da) * 1967-10-31 1968-12-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CH576963A5 (da) * 1972-03-10 1976-06-30 Ciba Geigy Ag
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
US4407803A (en) * 1981-08-17 1983-10-04 Abbott Laboratories Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
FI75308C (sv) * 1985-01-25 1988-06-09 Ky Carlson Project Kb Hydrostatiskt drivsystem.
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4661499A (en) * 1985-06-18 1987-04-28 Merck Frosst Canada, Inc. 2-[(substituted)-phenoxymethyl]quinolines
GB8602372D0 (en) * 1986-01-31 1986-03-05 Sandoz Ltd Organic compounds
US4851409A (en) * 1986-02-14 1989-07-25 Merck Frosst Canada Inc. 2-substituted quinoline dioic acids and pharmaceutical compositions
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids
US4968701A (en) * 1988-04-26 1990-11-06 E. I. Du Pont De Nemours And Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
EP0537191B1 (en) 1998-04-29
DE69129332D1 (de) 1998-06-04
AU664354B2 (en) 1995-11-16
EP0537191A4 (en) 1993-08-11
ATE165511T1 (de) 1998-05-15
IE911962A1 (en) 1991-12-18
WO1991019498A1 (en) 1991-12-26
AU8087391A (en) 1992-01-07
EP0537191A1 (en) 1993-04-21
ZA914456B (en) 1993-02-24
DE69129332T2 (de) 1998-08-27
US5204329A (en) 1993-04-20
JPH05507697A (ja) 1993-11-04
ES2114888T3 (es) 1998-06-16
CA2085002A1 (en) 1991-12-12
IL98425A (en) 1995-06-29
KR930700107A (ko) 1993-03-13

Similar Documents

Publication Publication Date Title
DK0537191T3 (da) Behandling af organtransplantat-afstødning
DK0484281T4 (da) Cyclosporiner
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
MY106038A (en) 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents.
FI931204A (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
DE69112192D1 (de) Antiherpes-Castanosperminester.
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
DE69110323D1 (de) Mikroskopobjektiv.
DE69110325T2 (de) Mikroskopobjektiv.
DK0745072T3 (da) 4-aminoderivater af 5-substitueret mycophenolsyre
DE69108668T2 (de) Kugelgelenkprothese.
FR2669539B1 (fr) Dispositif pour la circulation artificielle du sang et transfuseur autologue de sang total.
TR200103748T2 (tr) Organ nakli reddinin inhibe edilmesi için UK 114 proteinin kullanımı
KR910007540A (ko) 혈구 감소 장해의 예방ㆍ치료제
DE69103510D1 (de) Regale und Beschlag dafür.
Dzyubak Influence of Pseudomonas aeruginosa exotoxin on the permeability of the microcirculatory blood channel in the organs and tissues in the experiment.
RU96103721A (ru) Антгельминтное средство
ES2086449T3 (es) 2-terbutil-4-cloro-5-(4-ibutilmetilciclohexil)-metiltio-3(h)-piridazinona con actividad acaricida e insecticida.
FI903317A (fi) Foervarningskorg.
ITBO970296A0 (it) Sistema di posizionamento automatico per la lavorazione di lenti basat o sull'impiego di tecniche di visione artificiale.
ITRM940070V0 (it) "tavolo basso da salotto trasformabile in tavolo da pranzo e simili"
SU1602007A1 (ru) 6-(4,5-Дифенилтиенил-2)-3-тиа-1,2,4-триазин-5-он, проявляющий противовоспалительную и антимикробную активность
ES1015636Y (es) Vestidura de cuna perfeccionada.